397 related articles for article (PubMed ID: 10543275)
1. Carboxyterminal propeptide of type I procollagen in ELF: elevation in asbestosis, but not in pleural plaque disease.
Lammi L; Ryhänen L; Lakari E; Risteli J; Pääkkö P; Ruotsalainen EM; Lähde S; Kinnula VL
Eur Respir J; 1999 Sep; 14(3):560-4. PubMed ID: 10543275
[TBL] [Abstract][Full Text] [Related]
2. Propeptide levels of type III and type I procollagen in the serum and bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis.
Lammi L; Kinnula V; Lähde S; Risteli J; Pääkkö P; Lakari E; Ryhänen L
Eur Respir J; 1997 Dec; 10(12):2725-30. PubMed ID: 9493651
[TBL] [Abstract][Full Text] [Related]
3. Type III and type I procollagen markers in fibrosing alveolitis.
Lammi L; Ryhänen L; Lakari E; Risteli J; Pääkkö P; Kahlos K; Lähde S; Kinnula V
Am J Respir Crit Care Med; 1999 Mar; 159(3):818-23. PubMed ID: 10051256
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronan and procollagen type III aminoterminal peptide in serum and bronchoalveolar lavage fluid from patients with pulmonary fibrosis.
Milman N; Kristensen MS; Bentsen K
APMIS; 1995 Oct; 103(10):749-54. PubMed ID: 8534435
[TBL] [Abstract][Full Text] [Related]
5. [Pleural and parenchymal lung diseases from asbestos exposure. CT diagnosis].
Polverosi R; Vigo M; Citton O
Radiol Med; 2000 Nov; 100(5):326-31. PubMed ID: 11213409
[TBL] [Abstract][Full Text] [Related]
6. Fibronectin and procollagen 3 levels in bronchoalveolar lavage of asbestos-exposed human subjects and sheep.
Bégin R; Martel M; Desmarais Y; Drapeau G; Boileau R; Rola-Pleszczynski M; Massé S
Chest; 1986 Feb; 89(2):237-43. PubMed ID: 3943384
[TBL] [Abstract][Full Text] [Related]
7. Procollagen type III amino terminal propeptide concentrations in dogs with idiopathic pulmonary fibrosis compared with chronic bronchitis and eosinophilic bronchopneumopathy.
Heikkilä HP; Krafft E; Jespers P; McEntee K; Rajamäki MM; Clercx C
Vet J; 2013 Apr; 196(1):52-6. PubMed ID: 22909956
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous measurement of collagen type-VI-related antigen and procollagen type-III-N-propeptide levels in bronchoalveolar lavage.
Schaberg T; Orzechowski K; Oesterling C; Lode H; Schuppan D
Eur Respir J; 1994 Jul; 7(7):1221-6. PubMed ID: 7925898
[TBL] [Abstract][Full Text] [Related]
9. Cytological analysis of bronchoalveolar lavage fluid in asbestos-exposed workers.
Sartorelli P; Indini S; Bianchi F; D'Alessandro M; Bergantini L; Cameli P; Mazzei MA; Scancarello G; Barabesi L; Bargagli E
Med Lav; 2020 Oct; 111(5):379-387. PubMed ID: 33124609
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of serum aminoterminal propeptide of type III procollagen as an early marker of the active fibrotic process in asbestos-exposed workers.
Cavalleri A; Gobba F; Bacchella L; Ferrari D
Scand J Work Environ Health; 1991 Apr; 17(2):139-44. PubMed ID: 2047816
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronan and procollagen type III aminoterminal peptide in serum and bronchoalveolar lavage fluid in patients with pulmonary sarcoidosis.
Milman N; Kristensen MS; Bentsen K; Grode G; Frederiksen J
Sarcoidosis; 1995 Mar; 12(1):38-41. PubMed ID: 7617974
[TBL] [Abstract][Full Text] [Related]
12. Asbestos-related pleural disease and asbestosis: a comparison of CT and chest radiography.
Friedman AC; Fiel SB; Fisher MS; Radecki PD; Lev-Toaff AS; Caroline DF
AJR Am J Roentgenol; 1988 Feb; 150(2):269-75. PubMed ID: 3257311
[TBL] [Abstract][Full Text] [Related]
13. Clara cell protein (CC16) in serum and bronchoalveolar lavage fluid of subjects exposed to asbestos.
Petrek M; Hermans C; Kolek V; Fialová J; Bernard A
Biomarkers; 2002; 7(1):58-67. PubMed ID: 12101785
[TBL] [Abstract][Full Text] [Related]
14. [Markers of fibrogenesis in bronchoalveolar lavage and in serum of workers exposed to asbestos].
Salberini I; Rivolta G; Todaro A; Forni A; Annoni G; Chiappino G
Med Lav; 1991; 82(3):238-47. PubMed ID: 1795668
[TBL] [Abstract][Full Text] [Related]
15. Serum type III procollagen peptide: indicator for pulmonary fibrosis: II. Application in 80 asbestos insulation workers.
Okazaki I; Maruyama K; Kobayashi Y; Lilis R; Suzuki Y
Am J Ind Med; 1987; 11(4):439-46. PubMed ID: 3578296
[TBL] [Abstract][Full Text] [Related]
16. Significance of elevated procollagen-III-peptide and transforming growth factor-beta levels of bronchoalveolar lavage fluids from idiopathic pulmonary fibrosis patients.
Hiwatari N; Shimura S; Yamauchi K; Nara M; Hida W; Shirato K
Tohoku J Exp Med; 1997 Feb; 181(2):285-95. PubMed ID: 9163845
[TBL] [Abstract][Full Text] [Related]
17. Increased procollagen III aminoterminal peptide-related antigens and fibroblast growth signals in the lungs of patients with idiopathic pulmonary fibrosis.
Cantin AM; Boileau R; Bégin R
Am Rev Respir Dis; 1988 Mar; 137(3):572-8. PubMed ID: 3345038
[TBL] [Abstract][Full Text] [Related]
18. [The clinical utility of asbestos body counts in bronchoalveolar lavage fluid].
Takabe K; Tsukada Y; Shimizu T; Takagiwa J; Hirayama M; Nakayama M; Miura H; Akabane H; Takayama S; Aida S
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Nov; 35(11):1196-204. PubMed ID: 9493446
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of aminoterminal propeptide of type III procollagen and propeptide of human type I procollagen in systemic lupus erythematosus.
Villa-Manzano AI; Gamez-Nava JI; Salazar-Paramo M; Valera-Gonzalez IC; Garcia-Gonzalez A; Garcia-Gonzalez G; Morales-Romero J; Lopez-Olivo A; Galvan-Ramirez LM; Ruiz-Ruvalcaba R; Cardona-Muñoz EG; Gonzalez-Lopez L
Rheumatol Int; 2006 Jun; 26(8):712-6. PubMed ID: 16231121
[TBL] [Abstract][Full Text] [Related]
20. [A case of pulmonary fibrosis with many asbestos bodies in bronchoalveolar lavage fluid after exposure to asbestos and man-made mineral fibers].
Yatera K; Yoshii C; Morimoto Y; Hayashi T; Imanaga T; Yamato H; Kido M
Nihon Kokyuki Gakkai Zasshi; 2000 Oct; 38(10):801-6. PubMed ID: 11186929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
